The omicron variant is not a descendant of any...
molnupiravir
The results appear to surpass those seen with Merck's...
Merck’s investigational oral drug has generated much enthusiasm and...
Earlier, Merck had signed bilateral licensing deals with eight...
An independent group of medical experts monitoring the trial...
Molnupiravir is currently being tested in a global late-stage...
